{"database": "lobbying", "table": "lobbying_activities", "rows": [[2632098, "51b771a6-ab1f-47f3-8fcc-ee2a9267afe2", "Q2", "AMERICAN SOCIETY OF NEPHROLOGY", 80656, "AMERICAN SOCIETY OF NEPHROLOGY", 2021, "second_quarter", "HCR", "FY22 Congressional appropriations: \n-Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million \n-Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic.\n-Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies \n\nOther:\n-Enact the Living Donor Protection Act (HR1255 S377) \n-Enact the Jack Reyonlds Medigap Expansion Act (HR1676) \n-Increase access to home dialysis through at-home support, increased education, and removal of other barriers to at-home care", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", null, 40000, 0, 0, "2021-06-28T16:35:43.747000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2632098"], "units": {}, "query_ms": 174.50494493823498, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}